Misato, Japan

Masuharu Hirano

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.8

ph-index = 1


Location History:

  • Saitama, JP (2012)
  • Misato, JP (2019 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Masuharu Hirano

Introduction: Masuharu Hirano, an accomplished inventor based in Misato, Japan, is known for his significant contributions in the field of pharmaceuticals. With a total of four patents to his name, Hirano has focused on innovations that enhance healthcare solutions and therapeutic applications.

Latest Patents: Among Hirano's recent patents is an activator of peroxisome proliferator-activated receptor α. This invention details a compound represented by a specific formula that includes various possible substitutions, each contributing to its pharmacological effect. Additionally, he has innovated a solid dispersion that encapsulates a compound represented by General Formula (I), expanding the landscape of drug delivery systems.

Career Highlights: Throughout his career, Masuharu Hirano has collaborated with notable organizations, including Nippon Chemiphar Co., Ltd. and Shizuoka Prefectural University Corporation. His work has played a vital role in advancing pharmaceutical research and applications, impacting the industry on a substantial scale.

Collaborations: Hirano's collaborations with colleagues such as Tomio Yamakawa and Takafumi Muto have further enriched his research endeavors. Together, they have fostered an environment of innovation, leading to breakthroughs in therapeutic mechanisms and drug development.

Conclusion: Masuharu Hirano's dedication to innovation in pharmaceuticals demonstrates his commitment to improving healthcare through scientific research. With his impressive track record of patents and collaborations, he continues to inspire future generations of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…